Maternal serum placental growth hormone, insulin-like growth factors and their binding proteins at 20 weeks’ gestation in pregnancies complicated by gestational diabetes mellitus

This publication has 44 references indexed in Scilit:

• IGFBP-3 Inhibits Cytokine-Induced Insulin Resistance and Early Manifestations of Atherosclerosis
  PLOS ONE, 2013
• Maternal and Fetal Placental Growth Hormone and IGF Axis in Type 1 Diabetic Pregnancy
  PLOS ONE, 2012
• Placental hormones and the control of maternal metabolism and fetal growth
  Current Opinion in Endocrinology, Diabetes and Obesity, 2011
• Maternal serum placental growth hormone, but not human placental lactogen or insulin growth factor‐1, is positively associated with fetal growth in the first half of pregnancy
  Ultrasound in Obstetrics & Gynecology, 2010
• Evidence of a Role for Insulin-Like Growth Factor Binding Protein (IGFBP)-3 in Metabolic Regulation
  Endocrinology, 2010
• Maternal plasma concentrations of IGF-1, IGFBP-1, and C-peptide in early pregnancy and subsequent risk of gestational diabetes mellitus
  American Journal of Obstetrics and Gynecology, 2005
• Expression of Messenger RNA of Insulin-Like Growth Factors (IGFs) and IGF Binding Proteins (IGFBP1-6) in Placenta of Normal and Diabetic Pregnancy.
  Endocrine Journal, 1996
• Could abnormalities in insulin-like growth factors and their binding proteins during pregnancy result in gestational diabetes?
  Journal of Endocrinology, 1995
• The relationship between circulating andorgens, obesity, and hyperinsulinemia on serum insulin-like growth factor binding protein-1 in the polycystic ovarian syndrome
  American Journal of Obstetrics and Gynecology, 1995
• Regulation of Maternal Insulin-Like Growth Factor I by Placental Growth Hormone in Pregnancy. Possible Action of Maternal IGF-I on Fetal Growth
  Hormone Research, 1994